20 results match your criteria: "Dharmais Hospital National Cancer Center[Affiliation]"

Evaluation of low-dose pediatric chest CT examination using in-house developed various age-size pediatric chest phantoms.

Eur J Radiol

August 2024

Department of Physics, Institut Teknologi Sepuluh Nopember, Kampus ITS - Sukolilo Surabaya 600111, East Java, Indonesia. Electronic address:

Purpose: This study aims to develop Various Age-size Pediatric Chest Phantoms (VAPC) to evaluate low-dose protocol that approximates clinical conditions achieved by low organ-specific doses and optimal image quality among the challenges of pediatric size variations.

Methods: Three original pediatric data aged 1, 4, and 7 years were used as a reference for developing VAPC phantoms. Six protocols, namely standard dose (STD) and low dose (low mA and low kV) reconstructed using Filtered Back Projection (FBP) and iterative reconstruction (IR) algorithms, were investigated.

View Article and Find Full Text PDF
Article Synopsis
  • Breast cancer is a significant health issue in Indonesia, prompting a study to explore potential biomarkers, specifically mitochondrial DNA copy number (mtDNA-CN) and relative telomere length (RTL), which are linked to oxidative stress.
  • Researchers conducted a case-control study comparing blood samples from 175 breast cancer patients to 181 healthy individuals, utilizing quantitative real-time PCR for analysis.
  • Results showed that younger breast cancer patients (under 48) had higher mtDNA-CN and RTL compared to healthy individuals, indicating these biomarkers might be useful for early breast cancer risk assessment.
View Article and Find Full Text PDF
Article Synopsis
  • - The high mortality rate in breast cancer patients is often linked to metastases that resist systemic therapies, with circulating miRNAs-221 and miR-222 identified as key factors in this resistance by promoting cancer cell growth and survival.
  • - A study involving luminal subtype breast cancer patients treated with tamoxifen found that miR-221 levels significantly differed between patients with local recurrence and those without, indicating its potential role in predicting tamoxifen resistance.
  • - The findings suggest that measuring circulating miR-221/222 could help identify breast cancer patients at risk for treatment failure with tamoxifen, enabling earlier intervention and more effective treatment strategies.
View Article and Find Full Text PDF

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer.

ESMO Open

June 2023

Breast Center, Department of Obstetrics and Gynaecology and Comprehensive Cancer Center Munich, LMU University Hospital, Munich, Germany.

The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer (MBC) was published in 2021. A special, hybrid guidelines meeting was convened by ESMO and the Korean Society of Medical Oncology (KSMO) in collaboration with nine other Asian national oncology societies in May 2022 in order to adapt the ESMO 2021 guidelines to take into account the differences associated with the treatment of MBC in Asia. These guidelines represent the consensus opinions reached by a panel of Asian experts in the treatment of patients with MBC representing the oncological societies of China (CSCO), India (ISMPO), Indonesia (ISHMO), Japan (JSMO), Korea (KSMO), Malaysia (MOS), the Philippines (PSMO), Singapore (SSO), Taiwan (TOS) and Thailand (TSCO).

View Article and Find Full Text PDF

Approximately 60%-70% of breast cancer patients in Indonesia are diagnosed in the locally advanced stage. The stage carries a higher risk of lymph node metastasis which increases susceptibility to lymph obstruction. Hence, breast cancer-related lymphedema (BCRL) could present before axillary lymph node dissection (ALND).

View Article and Find Full Text PDF

Possible intraindividual evolution of SARS-CoV-2 in nasopharyngeal and anal swab in an octogenarian: a case report.

Germs

June 2022

PhD, National Research and Innovation Agency Republic of Indonesia, Jalan Raya Bogor KM 46 Cibinong, Bogor 16911, Jawa Barat, Indonesia.

Introduction: COVID-19 is an emerging infectious disease that remains to be further investigated.

Case Report: Here, we describe a case of COVID-19 in an octogenarian woman with comorbidities who slowly recovered during hospitalization, but died due to sudden cardiac death after 2 weeks of hospitalization. Her nasopharyngeal and anal swabs returned positive for SARS-CoV-2 by RT-PCR on day 7 of hospitalization.

View Article and Find Full Text PDF

Circulation microRNA expression profiles in patients with complete responses to chemoradiotherapy in nasopharyngeal carcinoma.

Noncoding RNA Res

December 2022

Department of Histology and Cell Biology, Faculty of Medicine, Nursing, and Public Health, Gadjah Mada University, Yogyakarta, Indonesia.

Background: Nasopharyngeal carcinoma (NPC) is endemic cancer in Southeast Asia with a relatively poor prognosis. Chemoradiotherapy is a primary treatment that advantages certain patients, particularly in the early stages. New predictive and prognostic biomarkers are required to guide and select the best treatment.

View Article and Find Full Text PDF

: The 7+3 regimen is still the main choice of remission induction chemotherapy in acute myeloid leukemia (AML). Successfully achieving complete remission (CR) and the time required to achieve it determine patient's survival. Hence, bone marrow examination on 14 day of chemotherapy is recommended to predict CR.

View Article and Find Full Text PDF

Ovarian carcinoma is one of the gynaecological malignancies that have the highest mortality rates due to its progressivity. Endothelin signalling plays a leading role in the progression of ovarian cancer through Epithelial-to-Mesenchymal Transition (EMT). Cisplatin commonly used as potent chemotherapy; however, its application hindered by its nephrotoxic effect.

View Article and Find Full Text PDF
Article Synopsis
  • - Approximately 70% of breast cancers are estrogen receptor-α (ERα)-positive, and tamoxifen, a selective ER modulator, is commonly used in treatment, but resistance to it can occur, often involving microRNAs like miR-221.
  • - A study compared breast cancer patients with and without local or metastatic recurrence after at least one year of tamoxifen therapy, focusing on the expression levels of miR-221.
  • - Results showed significantly higher expression of miR-221 in tamoxifen-resistant cases, suggesting that miR-221 may serve as a potential biomarker for predicting resistance to tamoxifen treatment in breast cancer patients.
View Article and Find Full Text PDF

Background: The ESR1 gene encodes Estrogen Receptor alpha (ERα), which plays a role in the tumourigenesis of breast cancer. A single nucleotide polymorphism (SNP) in intron 1 of this gene called ESR1 PvuII (rs2234693) has been reported to increase the risk of breast cancer. This study aimed to investigate the ESR1 PvuII polymorphism as a prognostic and predictive factor guiding the choice of therapy for advanced breast cancer.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the link between the triglyceride-glucose (TyG) index and breast cancer risk among individuals aged 19 and older in Indonesia, using a case-control design.
  • The findings showed that the TyG index was significantly higher in breast cancer patients compared to controls, with higher quartiles of the TyG index indicating increased odds of developing breast cancer.
  • The study concluded that a higher TyG index is associated with breast cancer risk in a nonlinear manner, along with other factors like smoking and contraceptive use.
View Article and Find Full Text PDF

The COVID-pandemic has shown significant impact on cancer care from early detection, management plan to clinical outcomes of cancer patients. The Asian National Cancer Centres Alliance (ANCCA) has put together the 9 "Ps" as guidelines for cancer programs to better prepare for the next pandemic. The 9 "Ps" are Priority, Protocols and Processes, Patients, People, Personal Protective Equipments (PPEs), Pharmaceuticals, Places, Preparedness, and Politics.

View Article and Find Full Text PDF

Objective: The COVID-19 pandemic has dramatically affected healthcare services around Asia. The Asian National Cancer Centres Alliance and the Asia-Pacific Organisation for Cancer Prevention collaborated to assess the mid- and long- term impact of COVID-19 to cancer care in Asia.

Methods: The two entities organised a combined symposium and post-meeting interactions among representatives of major cancer centres from seventeen Asian countries to outlining major challenges and countermeasures.

View Article and Find Full Text PDF

Birth Patterns and Delayed Breastfeeding Initiation in Indonesia.

J Prev Med Public Health

December 2020

Functional Medical Staff of Surgical Oncology Department, Dharmais Hospital-National Cancer Center, Jakarta, Indonesia.

Objectives: This study was conducted to examine the association between birth patterns (defined in terms of birth order and interval) with delayed breastfeeding initiation in Indonesia.

Methods: A cross-sectional study was carried out using data from the Indonesian Demographic and Health Survey 2017. The weighted number of respondents was 5693 women aged 15-49 years whose youngest living child was less than 2 years old.

View Article and Find Full Text PDF

The socioeconomic burden of cancer is growing rapidly in the Asian region, with a concentrated burden on low- and middle- income countries. The residents of this region, representing almost 60% of the global population, demonstrate an eclectic and complex nature, with huge disparities in ethnicity, sociocultural practices among others. The Asian National Cancer Centers Alliance (ANCCA) was established in 2005 by heads of several national cancer centers (NCCs) in the region to address common issues and concerns among Asian countries.

View Article and Find Full Text PDF

Background: Lung cancer is the most common cause of death in men in the world and in Indonesia where non-small cell carcinoma lung cancer (NSCLC) constitutes 85% of all lung cancer cases. The high mortality rate is due to a poor prognosis and is often diagnosed as having advanced stages. If it is known at the initial stage, the prognosis of lung cancer will be better.

View Article and Find Full Text PDF

Breast cancer is the most common cancer in Dharmais hospital. The treatment can give rise to breast cancer treatment-related lymphedema (BCRL) that will cause significant morbidities. Based on author's (BB) patient series in Dharmais hospital, BCRL occurred in 27.

View Article and Find Full Text PDF

Background: the expression of CD30, CD15, CD50, and PAX5 are used to help in confirming diagnosis of HL and sALCL; however data on the proportion of these markers have not been available. The study was aimed to identify the proportion of CD30, CD15, CD50 and PAX5 expressions and characteristics of patients with HL and sALCL at Dharmais National Cancer Center Hospital between 2005 and 2015.

Methods: a retrospective observational study was conducted using data from medical records and histopathological results of HL and sALCL adult patients who sought treatment at the hospital between 2005 and 2015.

View Article and Find Full Text PDF

Background: Cardiopulmonary bypass during tetralogy of Fallot corrective surgery is associated with oxidative stress, and contributes to peri-operative problems. Curcumin has been known as a potent scavenger of reactive oxygen species, which enhances the activity of antioxidants and suppresses phosphorylation of transcription factors involved in inflamation and apoptosis.

Objectives: To evaluate the effects of curcumin as an antioxidant by evaluating the concentrations of malondialdehyde and glutathione, activity of nuclear factor-kappa B, c-Jun N-terminal kinase, caspase-3, and post-operative clinical outcomes.

View Article and Find Full Text PDF